EPIX Pharmaceuticals, Inc. engages in the discovery and development of pharmaceuticals for imaging. The company offers imaging agents, which enable physicians to use magnetic resonance imaging (MRI) to obtain detailed information about specific disease processes. Its pipeline of MRI imaging pharmaceuticals include Vasovist, which completed phase III clinical trial for the detection of vascular disease; and EP-2104R, an injectable MRI contrast agent to detect blood clots using MRI. EPIX Pharmaceuticals has strategic alliance and collaboration agreements with Schering AG, Tyco/Mallinckrodt, GE Medical Systems, Philips Medical Systems, and Siemens Medical Systems. The company was formed as Metasyn, Inc. in 1988 and changed its name to EPIX Medical, Inc. in 1996. Further, EPIX Medical changed its name to EPIX Pharmaceuticals, Inc. in 2004. EPIX Pharmaceuticals is based in Cambridge, Massachusetts.
Posted by HitMe101 on :
![[Big Grin]](biggrin.gif)
![[Eek!]](eek.gif)